alexa
Reach Us +1-217-403-9671
Foula Televantou | OMICS International
ISSN 2472-1042

Pharmacoeconomics: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Foula Televantou

UK
Publications

Atomoxetine for the Treatment of Adults with Attention Deficit Hyperactivity Disorder: A Cost-Utility Analysis in Spain

Background: Attention-deficit hyperactivity disorder (ADHD) frequently persists into adulthood and leads to a significant burden of illness. Many adults with ADHD suffer from comorbid conditions such as substance and alcohol use disorders and anxiety. Atomoxetine is the only drug therapy approved in Spain for the treatment of adult ADHD. This study... Read More»

Antje Tockhorn, Foula Televantou, Kristina Karlsdotter and Tatiana Dilla

Research Article: Pharmacoeconomics 2015, 1:104

DOI: 10.4172/2472-1042.1000104

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Global Speakers in the subject

Global Experts in the subject

Top